2.3. Study Design
overweight, weight loss
The clinical trial was a 12-week, double-blind, randomized controlled trial to assess the efficacy and safety of DW2010 in regulating body and visceral fat in overweight individuals for weight loss purposes. After receiving written consent, subjects were randomly assigned to either the DW2010 or placebo group (